Skip to main content

Table 2 Discharge medications

From: Chemotherapy and adverse cardiovascular events in colorectal cancer patients undergoing surgical resection

Characteristics

Total (n = 412)

Chemotherapy (n = 200)

No chemotherapy (n = 212)

P value

Aspirin (n, %)

15 (14.1)

20 (10.0)

38 (17.9)

0.021

Thienopyridines

20 (4.9)

6 (3.0)

14 (6.6)

0.089

Anti-coagulant

9 (2.2)

5 (2.5)

4 (1.9)

0.670

Beta-blocker

101 (24.5)

44 (22.0)

57 (26.9)

0.249

ACE-I/ARB

117 (28.4)

47 (23.5)

70 (33.0)

0.032

Statin

173 (42.0)

75 (37.5)

98 (46.2)

0.073

Metformin

74 (18.0)

33 (16.5)

41 (19.3)

0.453

Sulphonylurea

40 (9.7)

21 (10.5)

19 (9.0)

0.598

DPP-4 inhibitors

9 (2.2)

6 (3.0)

3 (1.4)

0.271

Insulin

15 (3.6)

4 (2.0)

11 (5.2)

0.084

  1. ACE-I angiotensin-converting enzyme inhibitors; ARB angiotensin II receptor blockers; DPP-4 dipeptidyl peptidase-4